Company intelligence / Profile preview

Tri Locum Partners

New York, New York, United Statesadviserinfo.sec.gov ↗

Ownership: Private
Development stage: Other

Overview

Tri Locum Partners is an SEC-registered, New York-based healthcare investment hedge fund founded in 2019 by Dr. Prashanth Jayaram. The firm specializes in market-neutral equity long/short strategies focused on the global healthcare sector, including biotechnology, pharmaceuticals, medical devices, and services. It invests in both public and private companies and aims to generate superior idiosyncratic returns through deep fundamental research and proprietary portfolio construction[3][5][7].

Therapeutic areas: Other
Modalities: Not applicable (investment firm; does not develop therapeutics directly)
Industry: Investors

Beyond the preview

Go deeper on Tri Locum Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tri Locum Partners.

Explore the full profile